Welcome to our dedicated page for YCBDPA news (Ticker: YCBDPA), a resource for investors and traders seeking the latest updates and insights on YCBDPA stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect YCBDPA's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of YCBDPA's position in the market.
cbdMD, Inc. (NYSE American: YCBD, YCBDPA) will host a conference call on December 17, 2021, at 4:15 p.m. ET to discuss its September 30, 2021 fourth quarter and fiscal year-end financial results and business progress. The call follows a technical delay. Interested participants can join via domestic and international numbers provided. A teleconference replay will be available until January 15, 2022 and a webcast replay will be accessible until December 17, 2022.
cbdMD, Inc. (NYSE American: YCBD, YCBDpA) has appointed Dave Johnson as Senior Vice President of Business Development. With over 30 years in the consumer goods sector, including 20 years at PepsiCo (NASDAQ: PEP), Johnson will spearhead cbdMD's initiatives in expanding retail distribution across the U.S. He believes the CBD industry will experience significant growth in the next two years, positioning cbdMD to capitalize on this trend through its brands, including cbdMD and Paw CBD, and the new cbdMD Botanicals line.
cbdMD, Inc. (YCBD, YCBDPA) announced a multi-year exclusive agreement with Amify, an Amazon.com, Inc. (AMZN) partner, to launch CBD products on Amazon once the category is approved. This partnership includes cbdMD's leading products, such as gummies, tinctures, and skin care from cbdMD Botanicals. The agreement follows the growing interest in CBD since the Farm Bill's passage in 2018, positioning cbdMD to optimize its strategy for Amazon's platform. The company's Chairman emphasized readiness for market entry, enhancing cbdMD's distribution channels.
cbdMD, Inc. (NYSE American: YCBD, YCBDpA) has priced its public offering of 1,913,100 shares of 8.0% Series A Cumulative Convertible Preferred Stock at $7.50 each, aiming to raise gross proceeds of $14,348,250. Closing is expected around July 1, 2021, pending customary conditions. Shares are convertible at $6.00 per share unless certain trading conditions are met. The company plans to use net proceeds for working capital and general corporate purposes. ThinkEquity is the book-running manager for this offering.
